spironolactone
โ Previous: sotatercept | ๐ All Substances | ๐ Complete Table | Next: SR-18 โ
OPSS Properties
| Classifications | 6000 |
| Reason | WADA S5: Diuretics and Masking AgentsPrescription drug |
| Also Known As |
|
| Prohibited Because | WADA S5: Diuretics and Masking Agents (WADA Prohibited List S5: Diuretics and Masking Agents) Prescription drug |
| Added to Database | December 30, 2025 |
| Source Last Updated | February 27, 2024 |
| GUID | 3042aa67-2bfd-4473-94ae-ab2f5f0cf67c |
References
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 27O7W4T232 ยท CAS: 52-01-7
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C24H32O4S |
| Molecular Weight | 416.6 g/mol |
| IUPAC Name | S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate |
| InChIKey | LXMSZDCAJNLERA-ZHYRCANASA-N |
๐ Complete Table | ๐ All Substances
Substance 794 of 880